AbbVie has completed its acquisition of Aliada Therapeutics which includes Aliada’s disease-modifying therapy for Alzheimer’s disease.
Shilpa Gadgil, PhD (VP, Head of Process and Analytical Development, Head of CDMO Development) discusses Enzene's new technologies and the New Jersey site capabilities.
This paper explores the legal and regulatory framework around 3D drug printing, particularly for personalized medicine, ...
1. CPHI. Saudi Arabia Poised to Expand Domestic Manufacturing Eco-system as 30,000 Attendees join Inaugural CPHI Middle East. Press Release. Dec. 9, 2024. The draft guidance provides information on ...
Centogene NV and ROPAD consortium publish data from a landmark study identifying genetic variants that may respond to ...
LNPs have gained solid ground as a drug delivery system for mRNA due to their success in the vaccines arena.
The draft guidance provides information on the agency’s accelerated approval process and criteria for approval.
Lilly is investing $3 billion to expand its recently acquired manufacturing facility in Wisconsin, while Amgen is investing $1 billion to expand its facility in North Carolina.
A statistical procedure based on a quality range is proposed for demonstrating comparability between pre-change and ...
In this exclusive Drug Digest video interview an industry expert discusses key trends impacting solid dosage drug development ...